Literature DB >> 8880397

Folate, antifolates, and folate analogs in pediatric oncology.

M C Hum1, B A Kamen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8880397     DOI： 10.1007/bf00173686

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN： 0167-6997            Impact factor:   3.850


× No keyword cloud information.
  49 in total

1.  Uptake of methotrexate, aminopterin, and methasquin and inhibition of dihydrofolate reductase and of DNA synthesis in mouse small intestine.

Authors:  F S Philips; F M Sirotnak; J E Sodergren; D J Hutchison
Journal:  Cancer Res       Date:  1973-01       Impact factor: 12.701

Review 2.  Novel chemotherapeutic agents in clinical development.

Authors:  C Erlichman
Journal:  Curr Opin Oncol       Date:  1991-12       Impact factor: 3.645

3.  Successful carboxypeptidase G2 rescue in delayed MTX-elimination due to renal failure.

Authors:  M Hum; B A Kamen
Journal:  Pediatr Hematol Oncol       Date:  1995 Nov-Dec       Impact factor: 1.969

4.  New folate analogs of the 10-deaza-aminopterin series. Basis for structural design and biochemical and pharmacologic properties.

Authors:  F M Sirotnak; J I DeGraw; D M Moccio; L L Samuels; L J Goutas
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

5.  ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study.

Authors:  A L Jackman; G A Taylor; W Gibson; R Kimbell; M Brown; A H Calvert; I R Judson; L R Hughes
Journal:  Cancer Res       Date:  1991-10-15       Impact factor: 12.701

6.  Elevated dihydrofolate reductase and impaired methotrexate transport as elements in methotrexate resistance in childhood acute lymphoblastic leukemia.

Authors:  L H Matherly; J W Taub; Y Ravindranath; S A Proefke; S C Wong; P Gimotty; S Buck; J E Wright; A Rosowsky
Journal:  Blood       Date:  1995-01-15       Impact factor: 22.113

7.  Aminophylline for methotrexate-induced neurotoxicity.

Authors:  J C Bernini; D W Fort; J C Griener; B J Kane; W B Chappell; B A Kamen
Journal:  Lancet       Date:  1995-03-04       Impact factor: 79.321

8.  Polyglutamylation, an important element in methotrexate cytotoxicity and selectivity in tumor versus murine granulocytic progenitor cells in vitro.

Authors:  I Fabre; G Fabre; I D Goldman
Journal:  Cancer Res       Date:  1984-08       Impact factor: 12.701

9.  Structural features of 5,10-dideaza-5,6,7,8-tetrahydrofolate that determine inhibition of mammalian glycinamide ribonucleotide formyltransferase.

Authors:  S W Baldwin; A Tse; L S Gossett; E C Taylor; A Rosowsky; C Shih; R G Moran
Journal:  Biochemistry       Date:  1991-02-19       Impact factor: 3.162

10.  Development of an assay system for the detection and classification of methotrexate resistance in fresh human leukemic cells.

Authors:  S Rodenhuis; J J McGuire; R Narayanan; J R Bertino
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701
View more
  1 in total

1.  Phase 2 trial of pemetrexed in children and adolescents with refractory solid tumors: a Children's Oncology Group study.

Authors:  Anne B Warwick; Suman Malempati; Mark Krailo; Allen Melemed; Richard Gorlick; Matthew M Ames; Stephanie L Safgren; Peter C Adamson; Susan M Blaney
Journal:  Pediatr Blood Cancer       Date:  2012-06-28       Impact factor: 3.167
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.